Aspirin Foundation
Search
What is Aspirin?Uses of AspirinSuitabilityNews & EventsAbout the FoundationContact Us
  Home > News and Events > Media Releases > Another landmark for the world's wonder drug
News and Events man reading a news paper



News Briefs

Media Releases

Conferences
Photo Library


 


MEDIA STATEMENT
17th May 2007


ASPIRIN COULD REDUCE RISK OF PRE-ECLAMPSIA
(www.thelancet.com published online May 17, 2007)


The Aspirin Foundation welcomes this confirmation of the value of aspirin in certain complications of pregnancy. This is a subject which has been reported on a number of occasions with some results less positive than others.

The meta-analysis method of reviewing a range of clinical trials has confirmed that there is a positive benefit for certain women at risk of complications in pregnancy.

In accordance with the aspirin labelling, the Aspirin Foundation continue to advocate that pregnant women speak to their physician before aspirin use.

Aspirin should not be taken in the third trimester and only in the first and second trimester regularly on medical advice. Aspirin should not be taken when breast-feeding except under supervision of a doctor.




Ends